Publications by authors named "James Cleary"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

89

Total Likes

131

Extended Reach

557,058

Social Features

112
C
Chemical Perturbations Impacting Histone Acetylation Govern Colorectal Cancer Differentiation.
Pornlada Likasitwatanakul, Zhixin Li, Paul Doan, Sandor Spisak, Akhouri Kishore Raghawan, James M Cleary

Gastroenterology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Claudin 18.2 and Other Therapeutic Biomarkers in Gastric and Gastroesophageal Junction Adenocarcinomas.
Bella L Liu, James M Cleary, Jay Shi, Jason L Hornick, Lei Zhao

Am J Surg Pathol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938).
Liza C Villaruz, Jingxiao Jin, Hong Wang, James J Lee, Jason J Luke, James Cleary

Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets.
Vindhya Vijay, Negin Karisani, Lei Shi, Yu-Han Hung, Phuong Vu, James M Cleary

Cancer Discov· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.
Rishi Surana, Micaela Morgado, Ashwin Somasundaram, Bruno Bockorny, Colin D Weekes, James M Cleary, Nadine J McCleary

JCO Precis Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The state of global palliative care research: a bibliometric study.
Mevhibe B Hocaoglu, Grant Lewison, Hamish Sharp, Tania Pastrana, Eve Namisango, James Cleary

Ecancermedicalscience· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult Cancer Pain, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Robert A Swarm, Jeanie M Youngwerth, Julia L Agne, Magdalena Anitescu, Madhuri Are, James Cleary

J Natl Compr Canc Netw· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality indicators and patient outcome measures for palliative care in cancer patients: a systematic review.
Chase Peng Yun Ng, Moira Hegyi, Grant Lewison, Tania Pastrana, Eve Namisango, James Cleary

Ecancermedicalscience· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition.
Zackery A Ely, Zachary J Kulstad, Gurcan Gunaydin, Sudarsana Addepalli, Eva K Verzani, James M Cleary

Science· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Zenocutuzumab in Fusion-Positive Cancer.
Alison M Schram, Koichi Goto, Dong-Wan Kim, Teresa Macarulla, Antoine Hollebecque, James M Cleary

N Engl J Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours.
J Randolph Hecht, Jean-Marie Michot, David Bajor, Amita Patnaik, Ki Y Chung, James M Cleary

BJC Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.
Brandon M Huffman, Osama E Rahma, Kevin Tyan, Yvonne Y Li, Anita Giobbie-Hurder, James M Cleary

Cancer Immunol Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors.
Gregory M Cote, Bose S Kochupurakkal, Khanh Do, Andrea Bullock, Michael L Cheng, James M Cleary

Clin Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical perturbations impacting histone acetylation govern colorectal cancer differentiation.
Pornlada Likasitwatanakul, Zhixin Li, Paul Doan, Sandor Spisak, Akhouri Kishore Raghawan, James M Cleary

bioRxiv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer.
Harshabad Singh, Joanne Xiu, Kevin S Kapner, Chen Yuan, Raja R Narayan, James M Cleary

Clin Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer.
Urszula N Wasko, Jingjing Jiang, Tanner C Dalton, Alvaro Curiel-Garcia, A Cole Edwards, James M Cleary

Nature· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Petros Grivas, Elena Garralda, Funda Meric-Bernstam, Ingo K Mellinghoff, Lipika Goyal, James M Cleary

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity Adaptive Lists Design: A Practical Design for Phase I Drug Combination Trials in Oncology.
Massimiliano Russo, Francesco Mariani, James M Cleary, Geoffrey I Shapiro, Gregory M Coté

JCO Precis Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, James M Cleary, Nadine J McCleary

Cancer Immunol Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological Checkpoint Blockade in Anal Squamous Cell Carcinoma: Dramatic Responses Tempered By Frequent Resistance.
Thejus Jayakrishnan, Devvrat Yadav, Brandon M Huffman, James M Cleary

Curr Oncol Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma.
Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng, Nadine Jackson McCleary, James M Cleary

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptionally Active Human Papillomavirus Infection in a Minority of Esophageal Squamous Cell Carcinomas in North America.
Anna H Bauer, Khaled J Alkhateeb, Agoston T Agoston, Robert D Odze, Megha G Joshi, James M Cleary

Am J Surg Pathol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity.
Meng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, Lei Shi, Yi Xiao, James M Cleary

Science· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and therapeutic targets.
Vindhya Vijay, Negin Karisani, Lei Shi, Yu-Han Hung, Phuong Vu, James M Cleary

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis